QTRX quanterix.com: Multiplikator Forward P/S

Logo grafis Quanterix Corp (QTRX)

Quanterix Corporation (QTRX) has earned scientific acclaim for developing ultra-sensitive Simoa systems. The business's forward P/S clearly demonstrates market expectations, with the metric standing at 0.90. Growth prospects are supported by its status as a global leader in biomarker detection and the recruitment of top biochemical engineers who are developing advanced digital protein analysis methods for medicine.

quanterix.com - Rasio kapitalisasi marang dodolan sing dikarepake QTRX (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan quanterix.com (QTRX)

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:Quanterix Corp (QTRX)
Sampel barang Quanterix Corporation

To identify fundamental leaders within the analytics sector, the forward P/S ratio is critical, as it compares current market capitalization to expected annual revenue to measure the market valuation of future cash flows. In the case of Quanterix Corporation (QTRX), the dependence of this metric on the efficiency of production outsourcing and logistics allows the forward P/S trend to provide a real-time assessment of business value sensitivity to operational risks between quarterly reports.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott Laboratories)|TMO: Kapitalisasi marang prakiraan pendapatan|GE HealthCare Technologies - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Mettler-Toledo International MTD|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker BioSpin) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Life Sciences (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S semlerscientific.com (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network BFLY|Mesa Labs Corp - Rasio rega marang prakiraan pendapatan|quantum-si.com - Multiplikator Forward P/S|Rega forward marang dodolan NNOX (Nanox)|MASS: Multiplikator Forward P/S|CapsoVision, Inc. (CV) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan maxcyte.com|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer Inc)|Multiplikator Forward P/S Hyperfine Corp (HYPR)|Multiplikator Forward P/S FONR (fonar.com)|DXR (Daxor Corporation) - Rega mangsa ngarep marang pendapatan|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion Corporation (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences Inc|THMO (ThermoGenesis Holdings, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep talis.bio TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc (TTOO)